Humana Inc vs Occidental Petroleum Corporation — how do they compare? Humana Inc trades at $431.03 (market cap $46.49B), while Occidental Petroleum Corporation trades at $60.11 (market cap $60.26B). The key difference: Occidental Petroleum Corporation is the larger of the two by market cap, and Occidental Petroleum Corporation pays the higher dividend (1.86%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Occidental Petroleum Corporation for 92 Days on average.
| HUM | OXY | |
|---|---|---|
Market Cap | $46.49B | $60.26B |
Volume | 2,567,704 | 11,718,920 |
Sector | Health | Energy |
52-Week High | $431.03 | $66.24 |
52-Week Low | $163.67 | $38.92 |
Typical Hold Time | 51 Days | 92 Days |
Enterprise Value | $53.84B | $79.02B |
Dividend Yield | 0.91% | 1.86% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 2.37% today, with a bullish technical outlook supported by moving averages and strong institutional interest. The company shows steady revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent analyst upgrades and a $460.74 consensus price target suggest upside potential, while Medicare Advantage plan changes and fiduciary scrutiny present near-term headwinds.
The stock offers value with a low P/S ratio of 0.32x and consistent earnings beats, but faces margin pressure and regulatory risks. Institutional accumulation and positive technicals support a constructive outlook, though investors should monitor enrollment trends and cost management execution for sustained growth.
Occidental Petroleum (OXY) trades at $60.28, up 3.56% today, with a bullish technical outlook and strong recent earnings beats. The stock shows robust profitability with a 30.32% net margin and attractive valuation metrics, including a P/E of 17.78. Recent news highlights Goldman Sachs' upgrade and focus on the company's debt reduction and cash flow targets, while oil price volatility remains a key factor.
The investment outlook is positive, supported by analyst consensus favoring a buy rating and a $71.40 price target. Key opportunities include consistent earnings outperformance and strategic focus on carbon management, but risks involve exposure to fluctuating oil prices and high debt levels relative to equity.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →